Related content

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study

By Zambon Carlo-Federico   Pengo Vittorio   Padrini Roberto   Basso Daniela   Schiavon Stefania   Fogar Paola   Nisi Alessandra   Frigo Anna Chiara   Moz Stefania   Pelloso Michela   Plebani Mario  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 15-25

Future Medicine

Access to resources Recommend Favorite

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

By Scott Stuart A   Patel Manishkumar   Martis Suparna   Lubitz Steven A   van der Zee Sarina   Yoo Chang   Edelmann Lisa   Halperin Jonathan L   Desnick Robert J  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 297-307

Future Medicine

Access to resources Recommend Favorite

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

By Wu Alan HB   Wang Ping   Smith Andrew   Haller Christine   Drake Katherine   Linder Mark   Valdes Roland  

Pharmacogenomics, Vol. 9, Iss. 2, 2008-02 ,pp. : 169-178

Future Medicine

Access to resources Recommend Favorite

Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients

By Nakai Kenji   Tsuboi Jyunichi   Okabayashi Hitoshi   Fukuhiro Yoshiaki   Oka Takanori   Habano Wataru   Fukushima Noriko   Nakai Keiko   Obara Wataru   Fujioka Tomoaki   Suwabe Akira   Gurwitz David  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 713-719

Future Medicine

Access to resources Recommend Favorite

Association of Genetic Polymorphisms of CYP2C9 and VKORC1 with Bleeding Following Warfarin: A Case-Control Study

By  

Current Clinical Pharmacology, Vol. 11, Iss. 1, 2016-02 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite